BackEiger BioPharmaceuticals Overview

Eiger BioPharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for EIGR.

Quarterly SG&A Expenses

$4.70M
↓ 43.36% YoY

As of Dec 31, 2023

Annual SG&A Expenses (TTM)

$25.20M
↓ 13.4% YoY

Trailing 12 months ending Dec 31, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin